These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20858565)

  • 41. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
    Singh V; Bowden CL; Mintz J
    Int Clin Psychopharmacol; 2013 Mar; 28(2):91-5. PubMed ID: 23238761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depression and Suicidality Outcomes in the Treatment of Early Age Mania Study.
    Salpekar JA; Joshi PT; Axelson DA; Reinblatt SP; Yenokyan G; Sanyal A; Walkup JT; Vitiello B; Luby JL; Wagner KD; Nusrat N; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):999-1007.e4. PubMed ID: 26598475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone.
    Kemp DE; Johnson E; Wang WV; Tohen M; Calabrese JR
    J Clin Psychiatry; 2011 Sep; 72(9):1236-41. PubMed ID: 21457677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
    Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG
    J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania.
    Mousavi SY; Khezri R; Karkhaneh-Yousefi MA; Mohammadinejad P; Gholamian F; Mohammadi MR; Zeinoddini A; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):494-500. PubMed ID: 28409660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
    Tohen M; Ketter TA; Zarate CA; Suppes T; Frye M; Altshuler L; Zajecka J; Schuh LM; Risser RC; Brown E; Baker RW
    Am J Psychiatry; 2003 Jul; 160(7):1263-71. PubMed ID: 12832240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
    Ketter TA; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S45-53. PubMed ID: 17383011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.
    Bowden CL; Myers JE; Grossman F; Xie Y
    J Clin Psychiatry; 2004 May; 65(5):707-14. PubMed ID: 15163260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The empirical redefinition of the psychometric criteria for remission in bipolar disorder.
    Berk M; Ng F; Wang WV; Calabrese JR; Mitchell PB; Malhi GS; Tohen M
    J Affect Disord; 2008 Feb; 106(1-2):153-8. PubMed ID: 17655936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Creech RS; Welge JA; Jefferson L; Guerdjikova AI; Keck PE
    J Clin Psychiatry; 2010 May; 71(5):557-65. PubMed ID: 20361901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
    Kushner SF; Khan A; Lane R; Olson WH
    Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes.
    Houston JP; Ketter TA; Case M; Bowden C; Degenhardt EK; Jamal HH; Tohen M
    J Psychiatr Res; 2011 Feb; 45(2):169-73. PubMed ID: 20541220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Family conflict moderates response to pharmacological intervention in pediatric bipolar disorder.
    Townsend LD; Demeter CA; Youngstrom E; Drotar D; Findling RL
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):843-52. PubMed ID: 18315455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials.
    Vieta E; Durgam S; Lu K; Ruth A; Debelle M; Zukin S
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1882-91. PubMed ID: 26419293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study.
    Ghaemi SN; Gilmer WS; Goldberg JF; Zablotsky B; Kemp DE; Kelley ME; Bauer AD; Fleck J; Filkowski MM; Stan VA; Dunn RT
    J Clin Psychiatry; 2007 Dec; 68(12):1840-4. PubMed ID: 18162014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.
    Hirschfeld RM; Eerdekens M; Kalali AH; Canuso CM; Khan AA; Karcher K; Palumbo JM
    Int Clin Psychopharmacol; 2006 Jan; 21(1):11-20. PubMed ID: 16317312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.